Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time
Akeso and Summit Therapeutics’ PD-1xVEGF bispecific antibody ivonescimab has shown for the first time that it can extend patients’ lives.
Angus Liu
Aug 26, 2025 11:36am
J&J puts ImmunityBio on defense mode in bladder cancer
Apr 27, 2025 12:35pm
Halozyme sues Merck over subcutaneous Keytruda
Apr 24, 2025 2:41pm
Merck lays out subcutaneous Keytruda data amid patent brawl
Mar 27, 2025 11:00am
AstraZeneca inks $1.35B deal for subcutaneous cancer drugs
Mar 17, 2025 10:55am
Gilead's PrEP shows early promise in once-yearly dosing
Mar 11, 2025 2:30pm
